1hr 3mins

Br1dge Webinar 2: Emerging Immunotherapy - Applying Teplizumab in Practice

Broadcast Date
Presenter
Presented by PPME, scientific planning committee and expert faculty
Therapeutic Area
Diabetes

Join leading endocrinologist Dr. Alice Cheng and expert pediatric endocrinologist Dr. Kimber Simmons for the second session in our 2-part series on advancing care in Type 1 Diabetes (T1D). This webinar will focus on teplizumab — the first disease-modifying therapy shown to delay progression from Stage 2 to clinical T1D. Faculty will share personal experience, best practices, and practical insights to help you confidently integrate the treatment pathways into patient care.

Learning Objectives:

​By the end of this program, participants will be able to:

  1. Evaluate key evidence for teplizumab in the treatment of T1D
  2. Explore U.S. and Canadian practice habits and experiences with teplizumab
  3. Outline best practice for teplizumab administration, including infusion logistics, pre-infusion preparation, and coordination of care
  4. Identify common adverse events and apply evidence-based strategies for monitoring and managing patients before, during and after teplizumab infusion

Faculty:

Alice Cheng

MD, FRCPC

Toronto, ON

Kimber Simmons

MD, MS

Aurora, CO